CD83 polymorphisms and cervical cancer risk

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 319-322

  Yu, Kelly J ^a   Rader, Janet S ^b   Borecki, Ingrid ^b   Zhang, Zhengyan ^b   Hildesheim, Allan ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervix; Epidemiology; Genetics; Human papillomaviruses

Indexed keywords

CD83 ANTIGEN;

ADENOCARCINOMA; ADULT; ARTICLE; CANCER RISK; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; GROUPS BY AGE; HETEROZYGOTE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; UNITED STATES; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; ANTIGENS, CD38; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE CERVICAL NEOPLASMS;

EID: 67549128833     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.04.033     Document Type: Article

References (22)

1. Hildesheim A., and Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res. 89 (2002) 229-240
2. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., Schneidewind A., et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204 12 (2007) 3027-3036
3. Sun X.W., Kuhn L., Ellerbrock T.V., Chiasson M.A., Bush T.J., and Wright Jr. T.C. Human papillomavirus infection in women infected with the human immunodeficiency virus. New Engl. J. Med. 337 (1997) 1343-1349
4. Palefsky J.M., Minkoff H., Kalish L.A., Levine A., Sacks H.S., Garcia P., et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J. Natl. Cancer Inst. 91 (1999) 226-236
5. García-Piñeres A.J., Hildesheim A., Herrero R., Trivett M., Williams M., Atmetlla I., et al. Persistent human papillomavirus infection is associated with a generalized decrease in immune responsiveness in older women. Cancer Res. 66 22 (2006) 11070-11076
6. Breloer M., and Fleischer B. CD83 regulates lymphocyte maturation, activation and homeostasis. Trends Immunol. 29 4 (2008) 186-194
7. Kretschmer B., Lüthje K., Guse A.H., Ehrlich S., Koch-Nolte F., Haag F., et al. CD83 modulates B Cell function in vitro: increased IL-10 and reduced Ig secretion by CD83Tg B cells. PLoS ONE 2 1 (2007) e755
8. Zinser E., Lechmann M., Golka A., Lutz M.B., and Steinkasserer A. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200 3 (2004) 345-351
9. Scholler N., Hayden-Ledbetter M., Dahlin A., Hellstrom I., Hellstrom K.E., and Ledbetter J.A. Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 168 6 (2002) 2599-2602
10. Zhang Z., Borecki I., Nguyen L., Ma D., Smith K., Huettner P.C., et al. CD83 gene polymorphisms increase susceptibility to human invasive cervical cancer. Cancer Res. 67 23 (2007) 11202-11208
11. Lacey J.V., Brinton L.A., Abbas F.M., Barnes W.A., Gravitt P.E., Greenberg M.D., et al. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol. Biomarkers Prev. 8 12 (1999) 1079-1085
12. Lacey Jr. J.V., Frisch M., Brinton L.A., Abbas F.M., Barnes W.A., Gravitt P.E., et al. Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12 2 (2001) 153-161
13. Li J., Gerhard D.S., Zhang Z., Huettner P.C., Wright J., Nguyen L., et al. Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus. J. Clin. Microbiol. 41 12 (2003) 5563-5571
14. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 2 (2005) 263-265
15. Escoffier S. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol. 12 (1995) 921-927
16. R Development Core Team R. A language and environment for statistical computing. R Foundation for Statistical Computing (2004)
17. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am. J. Hum. Genet. 70 2 (2002) 425-434
18. Bulk S., Berkhof J., Bulkmans N.W., Zielinski G.D., Rozendaal L., van Kemenade F.J., et al. Preferential risk of HPV16 for squamous cell carcinoma and of HPV18 for adenocarcinoma of the cervix compared to women with normal cytology in The Netherlands. Br. J. Cancer 94 1 (2006) 171-175
19. Burk R.D., Terai M., Gravitt P.E., Brinton L.A., Kurman R.J., Barnes W.A., et al. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 63 (2003) 7215-7220
20. Loman N., Johannsson O., Kristoffersson U., Olsson H., and Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J. Natl. Cancer Inst. 93 16 (2001) 1215-1223
21. Albano W.A., Recabaren J.A., Lynch H.T., Campbell A.S., Mailliard J.A., Organ C.H., et al. Natural history of hereditary cancer of the breast and colon. Cancer 50 2 (1982) 360-363
22. Boland C.R. Familial colonic cancer syndromes. West J. Med. 139 (1983) 351-359